Table 1 Patient characteristics
From: UMOD as a susceptibility gene for end-stage renal disease
ESRD patients, n = 1142 | |
|---|---|
Age, years | 47.7 ± 13.5 |
Sex: male, n (%) | 662 (58.0) |
Primary disease: | |
- glomerulonephritis, n (%) | 242 (21.2) |
- autosomal dominant polycystic kidney disease, n (%) | 155 (13.6) |
- pyelonephritis, n (%) | 128 (11.2) |
- renal vascular disease, n (%) | 110 (9.6) |
- IgA nephropathy, n (%) | 89 (7.8) |
- diabetes types I and II, n (%) | 47 (4.1) |
- other/uncertain etiology, n (%) | 371 (32.5) |
Kidney donors, n = 1184 | |
Age, years | 44.5 ± 14.3 |
Sex: male, n (%) | 602 (50.8) |
Living donors, n (%) | 282 (23.8) |
- from which related donors, n (%) | 164 (58.2) |
Matched donor-recipient pairs, n = 1066 | |
Recipient age, years | 48.1 ± 13.5 |
Recipient sex: male, n (%) | 620 (58.2) |
Donor age, years | 44.6 ± 14.3 |
Donor sex: male, n (%) | 540 (50.7) |
Living donors, n (%) | 261 (24.5) |
Cold ischemia time, hours | 17.4 [9.0-23.0] |
Total warm ischemia time, minutes | 40.0 [34.0-51.0] |
Delayed graft function, n (%) | 332 (31.1) |
Post-transplant follow-up duration, years | 5.5 [3.0-8.7] |
Acute organ rejection episodes history, n (%) | 368 (34.5) |
Death-censored graft failure, n (%) | 172 (16.1) |
Death with a functioning graft, n (%) | 182 (17.1) |
Renal transplant recipients with urine available, n = 282 | |
Age, years | 52.1 ± 12.3 |
Sex: male, n (%) | 152 (53.9) |
Urine collection time point, years after transplantation | 4.2 [2.2-6.1] |